Antigingivitis product warnings on periodontitis symptoms advised by FDA panel.
This article was originally published in The Tan Sheet
Executive Summary
ANTIGINGIVITIS PRODUCT LABEL WARNING FOR PERIODONTITIS SIGNS recommended by FDA's Dental Plaque Subcommittee during its meeting in Gaithersburg, Md. May 28. The label warning suggested by the advisory group states: "See your dentist immediately before use if you have pain or swelling of the gums, pus from the gumline, loose teeth or increased spacing between teeth. These signs or symptoms may be a sign of periodontitis, a more serious form of gum disease." The subcommittee also agreed a warning should be included on labeling that "If gingivitis, redness or bleeding persist for more than two weeks, see your dentist." Wording of the warnings may be changed to fit with FDA's proposed revisions to the OTC label format.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning